Article
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.
Circulation research - 6 Aug 2010
Dobaczewski Marcin, Bujak Marcin, Li Na, Gonzalez-Quesada Carlos, Mendoza Leonardo H, Wang Xiao-Fan, Frangogiannis Nikolaos G
Abstract excerpt
RATIONALE: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-beta/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. OBJECTIVE: The present study explores the mechanisms responsible for the fibrogenic effects of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
